New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (409)	2/16/2002 2:29:40 PM
From: JOEBT1	Read Replies (2) of 724

Richard--I agree with you, with 1$/per share earnings in sight this year and an IPO of DGI in a year or two the stock could be a big winner. I've been building a position for about a year thanks to your leadership. What happened to Peter Suzman?--It seems all his posts have been deleted as well as his profile. I'm enamored of CTIC (yes I know Rosenwald is a persistent seller) with an approved drug, Trisenox, and PG-Taxol, PG-Campothecin in PI and PII trials. PG-Taxol is in 8 PI/II trials. According to CTIC PG-Taxol is 5 to 10 times more effective than Taxol with very low side effects. They are doing both combo and single drug trials. Trials include ovarian, breast, colon and nslc cancers. Preliminary results with refractory patients exciting--for ovarian patients, 8 out of 16 responses, 4 PR and 4 stable. Other positive preliminary results also. Presenting 5 reports at ASCO on PI/II trials. If you have an opinion on CTIC, I'd be very much interested. Joe

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next